Edwards Lifesciences

$212.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.63 (-2.14%) Today
$0.00 (0.00%) As of 4:52 PM EDT after-hours

Why Robinhood?

You can buy or sell EW and other stocks, options, ETFs, and crypto commission-free!

About EW

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. Read More The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..

Employees
12,800
Headquarters
Irvine, California
Founded
1958
Market Cap
44.10B
Price-Earnings Ratio
62.18
Dividend Yield
0.00
Average Volume
1.15M
High Today
$217.39
Low Today
$210.89
Open Price
$216.07
Volume
1.00M
52 Week High
$226.41
52 Week Low
$136.44

Collections

EW News

ReutersAug 22

Edwards Lifesciences recalls delivery system for Sapien heart valves

49
BenzingaAug 22

Edwards Lifesciences Corporation - Edwards Lifesciences Shares Fall As FDA Reports Recall Of Sapien 3 Ultra

203
ReutersAug 16

Edwards Lifesciences, Medtronic heart valves win FDA approval for expanded use

116

EW Earnings

$0.91
$1.07
$1.22
$1.38
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 22, After Hours

More EW News

Wall Street JournalAug 14

Investors Heart Edwards Lifesciences

19
ReutersAug 5

Edited Transcript of EW earnings conference call or presentation 23-Jul-19 9:00pm GMT

10
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.